86 related articles for article (PubMed ID: 25851028)
41. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review.
McInnes MD; Hibbert RM; Inácio JR; Schieda N
Radiology; 2015 Nov; 277(2):413-23. PubMed ID: 26020440
[TBL] [Abstract][Full Text] [Related]
42. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma.
van den Esschert JW; van Gulik TM; Phoa SS
Dig Surg; 2010; 27(1):46-55. PubMed ID: 20357451
[TBL] [Abstract][Full Text] [Related]
43. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.
Thomeer MG; E Bröker ME; de Lussanet Q; Biermann K; Dwarkasing RS; de Man R; Ijzermans JN; de Vries M
Diagn Interv Radiol; 2014; 20(3):193-9. PubMed ID: 24509184
[TBL] [Abstract][Full Text] [Related]
44. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.
Hussain SM; Terkivatan T; Zondervan PE; Lanjouw E; de Rave S; Ijzermans JN; de Man RA
Radiographics; 2004; 24(1):3-17; discussion 18-9. PubMed ID: 14730031
[TBL] [Abstract][Full Text] [Related]
45. Focal Benign Liver Lesions and Their Diagnostic Pitfalls.
Reizine E; Mulé S; Luciani A
Radiol Clin North Am; 2022 Sep; 60(5):755-773. PubMed ID: 35989043
[TBL] [Abstract][Full Text] [Related]
46. Hypointense hepatic lesions depicted on gadobenate dimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy.
Hwang HS; Kim SH; Jeon TY; Choi D; Lee WJ; Lim HK
Korean J Radiol; 2009; 10(3):294-302. PubMed ID: 19412518
[TBL] [Abstract][Full Text] [Related]
47. Hyperintense Liver Masses at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI: Imaging Appearances and Clinical Importance.
Fujita N; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Kakihara D; Nakayama T; Morita K; Ishimatsu K; Honda H
Radiographics; 2020; 40(1):72-94. PubMed ID: 31834849
[TBL] [Abstract][Full Text] [Related]
48. Hepatic neoplasms associated with contraceptive and anabolic steroids.
Ishak KG
Recent Results Cancer Res; 1979; 66():73-128. PubMed ID: 219453
[TBL] [Abstract][Full Text] [Related]
49. Diagnosis and Follow-up of Incidental Liver Lesions in Children.
Karmazyn B; Rao GS; Johnstone LS; Severance TS; Ferguson MJ; Marshalleck FE; Molleston JP
J Pediatr Gastroenterol Nutr; 2022 Mar; 74(3):320-327. PubMed ID: 34984985
[TBL] [Abstract][Full Text] [Related]
50. The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase.
Jeong WK; Kim YK; Song KD; Choi D; Lim HK
Clin Mol Hepatol; 2013 Dec; 19(4):360-6. PubMed ID: 24459639
[TBL] [Abstract][Full Text] [Related]
51. Focal nodular hyperplasia and hepatic adenoma: a review.
Lizardi-Cervera J; Cuéllar-Gamboa L; Motola-Kuba D
Ann Hepatol; 2006; 5(3):206-11. PubMed ID: 17060885
[TBL] [Abstract][Full Text] [Related]
52. [Benign focal hepatic lesions].
Baroud S; Bastati N; Prosch H; Schima W; Ba-Ssalamah A
Radiologe; 2011 Aug; 51(8):688-96. PubMed ID: 21809146
[TBL] [Abstract][Full Text] [Related]
53. Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI.
Palmucci S
World J Hepatol; 2014 Jul; 6(7):477-85. PubMed ID: 25067999
[TBL] [Abstract][Full Text] [Related]
54. A case of hepatocellular carcinoma arising within large focal nodular hyperplasia with review of the literature.
Petsas T; Tsamandas A; Tsota I; Karavias D; Karatza C; Vassiliou V; Kardamakis D
World J Gastroenterol; 2006 Oct; 12(40):6567-71. PubMed ID: 17072995
[TBL] [Abstract][Full Text] [Related]
55. Focal nodular hyperplasia and hepatocellular adenoma: current views.
Dimitroulis D; Charalampoudis P; Lainas P; Papanikolaou IG; Kykalos S; Kouraklis G
Acta Chir Belg; 2013; 113(3):162-9. PubMed ID: 24941710
[TBL] [Abstract][Full Text] [Related]
56. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma.
Nagorney DM
World J Surg; 1995; 19(1):13-8. PubMed ID: 7740799
[TBL] [Abstract][Full Text] [Related]
57. Hepatocellular adenoma: An unsolved diagnostic enigma.
Renzulli M; Clemente A; Tovoli F; Cappabianca S; Bolondi L; Golfieri R
World J Gastroenterol; 2019 May; 25(20):2442-2449. PubMed ID: 31171888
[TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance imaging (MRI) and diseases of the liver and biliary tract. Part 1. Basic principles, MRI in the assessment of diffuse and focal hepatic disease.
Macdonald GA; Peduto AJ
J Gastroenterol Hepatol; 2000 Sep; 15(9):980-91. PubMed ID: 11059926
[TBL] [Abstract][Full Text] [Related]
59. Management of focal nodular hyperplasia and hepatocellular adenoma.
Mentha G; Rubbia-Brandt L; Howarth N; Majno P; Morel P; Terrier F
Swiss Surg; 1999; 5(3):122-5. PubMed ID: 10414183
[TBL] [Abstract][Full Text] [Related]
60. Key CT and MRI findings of drug-associated hepatobiliary and pancreatic disorders.
Ichikawa S; Goshima S
Jpn J Radiol; 2024 Mar; 42(3):235-245. PubMed ID: 37926781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
